Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets, Volume 10 - Number 3
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
, 10(3): 268 - 278N. Ahmed, K. Abubaker, J. Findlay and M. Quinn
DOI: 10.2174/156800910791190175
In Vivo Inhibition of the Estrogen Sulfatase Enzyme and Growth of DMBA-Induced Mammary Tumors by Melatonin
, 10(3): 279 - 286A. Gonzalez, V. Alvarez-Garcia, C. Martinez-Campa, M.D. Mediavilla, C. Alonso-Gonzalez, E.J. Sanchez-Barcelo and S. Cos
DOI: 10.2174/156800910791190201
CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
, 10(3): 287 - 306J.L. Hao, P.J. Cozzi, A. Khatri, C.A. Power and Y. Li
DOI: 10.2174/156800910791190193
Persistent P21Cip1 Induction Mediates G1 Cell Cycle Arrest by Methylseleninic Acid in DU145 Prostate Cancer Cells
, 10(3): 307 - 318Z. Wang, H.-J. Lee, Y. Chai, H. Hu, L. Wang, Y. Zhang, C. Jiang and J. Lu
DOI: 10.2174/156800910791190238
Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy
, 10(3): 319 - 331A.S. Azmi, P.A. Philip, A. Aboukameel, Z. Wang, S. Banerjee, S.F. Zafar, A.-S. Goustin, K. Almhanna, D. Yang, F.H. Sarkar and R.M. Mohammad
DOI: 10.2174/156800910791190229
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
, 10(3): 332 - 342I. Kenessey, M. Keszthelyi, Z. Kramer, J. Berta, A. Adam, J. Dobos, M. Mildner, B. Flachner, S. Cseh, G. Barna, B. Szokol, L. Orfi, G. Keri, B. Dome, W. Klepetko, J. Timar and J. Tovari
DOI: 10.2174/156800910791190184
A Novel Cancer Targeting Approach Based on Estrone Anchored Stealth Liposome for Site-Specific Breast Cancer Therapy
, 10(3): 343 - 353S.R. Paliwal, R. Paliwal, N. Mishra, A. Mehta and S.P. Vyas
DOI: 10.2174/156800910791190210
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net